Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal | Zendy

Hari Jung Chand | Zendy; Komal Raj Rijal | Zendy; Biswas Neupane | Zendy; Vijay Sharma | Zendy; Bharat Jha | Zendy

Open Access

Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal

Author(s) -

Hari Jung Chand,

Komal Raj Rijal,

Biswas Neupane,

Vijay Sharma,

Bharat Jha

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.4228

Subject(s) - nalidixic acid , ampicillin , salmonella , ciprofloxacin , salmonella typhi , typhoid fever , microbiology and biotechnology , chloramphenicol , paratyphoid fever , trimethoprim , serotype , multiple drug resistance , drug resistance , sulfamethoxazole , medicine , antibiotics , biology , bacteria , escherichia coli , biochemistry , genetics , gene

Enteric fever is endemic in Nepal and poses a significant public health burden. The first-line drugs ampicillin, chloramphenicol, and cotrimoxazole have not been part of empirical therapy for two decades due to the development of multidrug-resistant Salmonella strains. The objective of this study was to determine the antibiogram pattern of Salmonella serovars isolated from the blood of clinically suspected enteric fever patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research